Product Description
Description: Torque’s Cfurotor-CV is a combination of broad-spectrum cephalosporin antibiotic and beta-lactamase inhibitor which is used to treat infections caused by various gram negative and positive bacteria.
Pharmaceutical Dosage Form: Tablet
Route of Administration: Oral
Composition: Each film coated tablet contains:
Cefuroxime Axetil IP
Eq. to Cefuroxime ……………………. 250 mg
Potassium Clavulanate Diluted IP
equivalent to Clavulanic Acid 125 mg
Excipients
Excipients …………………………………….. q.s.
Mechanism of Action. Cefuroxime axetil undergoes hydrolysis by esterase enzymes to convert into its active form, cefuroxime. Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. Clavulanic acid is a beta-lactam, structurally related to penicillins, which possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in micro-organisms resistant to penicillins.
Indications: Torque’s Cfurotor-CV is indicated for lower & upper respiratory tract infection, UTI, gynecological infection, skin or soft tissue infection etc.
Dosage: As directed by the physician.
Storage: Store protected from moisture, at a temperature not exceeding 30°C
Presentation: 10X1X10 Tablets
Side effects:
Headache
Dizziness
Diarrhea
Nausea
Abdominal pain
Increased hepatic enzyme levels
Contraindications: Torque’s Cfurotor-CV is contraindicated in patients with a known allergy to the cephalosporin group of antibiotics. or excipients, during pregnancy and lactation, in patients with severe hepatic failure or renal impairment.
Drug Interactions: Torque’s Cfurotor-CV can cause drug interaction with following drugs:
Probenecid
Oral contraceptives
Oral anticoagulants
